Development of an enantioselective process for the manufacture of SRI/5-HT2A Inhibitor PF-03699518-42

Shu Yu

Sarah Griffin

Teresa Makowski

Christopher O[apos]donnell

Jennifer Rutherford

Lawrence Vincent

Michael Witt

Longfei Xie

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com